Exclusive Provider Organization (EPO)

An Exclusive Provider Organization (EPO) is a type of managed care health insurance plan that combines features of Health Maintenance Organizations (HMOs) and Preferred Provider Organizations (PPOs). EPOs typically have lower out-of-pocket costs than PPOs and provide more freedom to choose healthcare providers than HMOs.

Here are some key features of an EPO:

  • Network of providers: Like an HMO, an EPO has a network of healthcare providers, including doctors and hospitals, that participants must use in order to receive coverage.

  • No out-of-network coverage: Unlike a PPO, an EPO typically does not provide coverage for out-of-network providers, except in certain emergency situations.

  • No referrals required: EPOs do not require participants to choose a primary care physician or obtain referrals in order to see specialists.

  • Lower out-of-pocket costs: EPOs typically have lower out-of-pocket costs than PPOs, but higher than HMOs.

  • Flexibility: EPOs provide more flexibility in choosing healthcare providers than HMOs, but less than PPOs.

Example:

An example of an EPO is a health insurance plan offered by an employer to its employees. The plan has a network of healthcare providers, including doctors and hospitals, that participants must use in order to receive coverage. Participants are not required to choose a primary care physician or obtain referrals in order to see specialists. The plan has lower out-of-pocket costs than a PPO, but higher than an HMO. Participants have more flexibility in choosing healthcare providers than with an HMO, but less than with a PPO. The EPO plan is an option for employees who want lower out-of-pocket costs than a PPO, but more flexibility than an HMO.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.